These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1973238)

  • 1. Type III allergic reaction after infusion of immunoglobulins.
    Hachimi-Idrissi S; de Schepper J; de Waele M; Dab I; Otten J
    Lancet; 1990 Jul; 336(8706):55. PubMed ID: 1973238
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming recurrent spontaneous abortions in women suffering from IgG subclass deficiency: high efficiency of low dose intravenous immunoglobulins treatment.
    Manfredi G; Dell'Aera L; Liguori R
    Eur Ann Allergy Clin Immunol; 2015 May; 47(3):91-4. PubMed ID: 25951147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclass deficiency and the day-care generation.
    Lawton AR
    Pediatr Infect Dis J; 1999 May; 18(5):462-6. PubMed ID: 10353521
    [No Abstract]   [Full Text] [Related]  

  • 4. Fall in the neutrophil count during immunoglobulin infusion.
    Tampi R
    Aust N Z J Med; 1989 Oct; 19(5):515-6. PubMed ID: 2511829
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective IgG subclass deficiencies in patients with recurrent sinopulmonary infections: report of two cases.
    Chou CC; Hsieh KH; Lin YZ; Ting CK; Wang JY
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):129-33. PubMed ID: 3219160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema multiforme after intravenous immunoglobulin.
    Rodeghiero F; Castaman G; Vespignani M; Dini E; Bertazzoni M
    Blut; 1988 Mar; 56(3):145. PubMed ID: 3128353
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin treatment of patients with selective IgG subclass and IgA deficiency states.
    Björkander J; Oxelius VA; Söderström R; Hanson LA
    Monogr Allergy; 1988; 23():160-7. PubMed ID: 3386638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of human immunoglobulin preparation in resistance to immunosuppressive therapy in a male patient with nephrotic syndrome].
    Moskaleva ES; Katysheva OV; Ruzhitskaia EA; Nevstrueva VV; Ivanina EK; Ignatova MS
    Ter Arkh; 1999; 71(6):75-6. PubMed ID: 10420467
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravenous immunoglobulin in the treatment of malignant epilepsy in children].
    Sterio M; Gebauer E; Vucicević G; Zalisevskij G; Felle D; Kolarov N
    Wien Klin Wochenschr; 1990 Apr; 102(8):230-3. PubMed ID: 2111611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions of intravenous immunoglobulin.
    Al-Wahadneh AM; Khriesat IA; Kuda EH
    Saudi Med J; 2000 Oct; 21(10):953-6. PubMed ID: 11369961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgG subclass deficiency].
    Takamoto M; Agematsu K
    Ryoikibetsu Shokogun Shirizu; 2000; (32):89-91. PubMed ID: 11212833
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous IgG replacement therapy is safe and well tolerated in lung transplant recipients.
    Shankar T; Gribowicz J; Crespo M; Silveira FP; Pilewski J; Petrov AA
    Int Immunopharmacol; 2013 Apr; 15(4):752-5. PubMed ID: 23499641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anaphylactic shock reaction following intravenous administration of 7S immunoglobulin in patients with hypogammaglobulinemia, especially in children with acute lymphoblastic leukemia (ALL)].
    Manzke H; Seifert J
    Klin Padiatr; 1987; 199(4):274-8. PubMed ID: 3116320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of intravenous immunoglobulins: recommendations of a consensus conference of the working group of immunology of the Italian Society of Pediatrics.
    Ann Allergy; 1989 Apr; 62(4):362-7. PubMed ID: 2495747
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterisation, standardisation and control of therapeutic immunoglobulin preparations intended for intravenous use.
    Thorpe R; Bird CR; Brasher MD
    J Infect; 1987 Jul; 15 Suppl 1():13-9. PubMed ID: 3117896
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
    Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home self-administration of intravenous immunoglobulin therapy in children.
    Kobayashi RH; Kobayashi AD; Lee N; Fischer S; Ochs HD
    Pediatrics; 1990 May; 85(5):705-9. PubMed ID: 2109852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
    McCormack PL
    BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella pneumonia as the presenting manifestation of immunodeficiency.
    Saulsbury FT
    Clin Pediatr (Phila); 1991 Sep; 30(9):555-8. PubMed ID: 1804588
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii.
    Hassett J; Meyers S; McFarland L; Mulligan ME
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S266-8. PubMed ID: 7548571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.